These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15207117)

  • 1. [Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)].
    Fernández-Cuenca F; Pascual A; Ribera A; Vila J; Bou G; Cisneros JM; Rodríguez-Baño J; Pachón J; Martínez-Martínez L;
    Enferm Infecc Microbiol Clin; 2004 May; 22(5):267-71. PubMed ID: 15207117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization and determination of antibiotic resistance profiles of a single clone Acinetobacter baumannii strains isolated from blood cultures].
    Karagöz A; Baran I; Aksu N; Acar S; Durmaz R
    Mikrobiyol Bul; 2014 Oct; 48(4):566-76. PubMed ID: 25492652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis.
    Cetin ES; Durmaz R; Tetik T; Otlu B; Kaya S; Calişkan A
    Am J Infect Control; 2009 Feb; 37(1):56-64. PubMed ID: 18834735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.
    Chen J; Li H; Yang J; Zhan R; Chen A; Yan Y
    Int J Environ Res Public Health; 2015 Aug; 12(8):10093-105. PubMed ID: 26308028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: multicenter national study GEIH-REIPI-Ab 2010].
    Fernández-Cuenca F; Tomás-Carmona M; Caballero-Moyano F; Bou G; Martínez-Martínez L; Vila J; Pachón J; Cisneros JM; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2013 Jan; 31(1):4-9. PubMed ID: 22939566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis.
    Mohajeri P; Farahani A; Feizabadi MM; Norozi B
    Indian J Med Microbiol; 2015; 33(1):87-91. PubMed ID: 25560008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
    Al-Agamy MH; Jeannot K; El-Mahdy TS; Shibl AM; Kattan W; Plésiat P; Courvalin P
    Microb Drug Resist; 2017 Jul; 23(5):556-562. PubMed ID: 27854148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico.
    Bocanegra-Ibarias P; Peña-López C; Camacho-Ortiz A; Llaca-Díaz J; Silva-Sánchez J; Barrios H; Garza-Ramos U; Rodríguez-Flores AM; Garza-González E
    Int J Antimicrob Agents; 2015 Mar; 45(3):309-13. PubMed ID: 25561030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread of a single clone Acinetobacter baumannii strain in an intensive care unit of a teaching hospital in Turkey.
    Güdücüoglu H; Durmaz R; Yaman G; Cizmeci Z; Berktas M; Durmaz B
    New Microbiol; 2005 Oct; 28(4):337-43. PubMed ID: 16386018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
    Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
    Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain.
    Oteo J; García-Estébanez C; Migueláñez S; Campos J; Martí S; Vila J; Domínguez MA; Docobo F; Larrosa N; Pascual A; Pintado V; Coll P;
    J Infect; 2007 Sep; 55(3):260-6. PubMed ID: 17570530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
    Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California.
    Valentine SC; Contreras D; Tan S; Real LJ; Chu S; Xu HH
    J Clin Microbiol; 2008 Aug; 46(8):2499-507. PubMed ID: 18524965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.